Emily M. Leproust
Chief Executive Officer at Twist Bioscience Corporation
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Twist Bioscience Corporation, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
GeneDx Holdings Corp. June 20, 202495.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 3, 2026 | Twist Bioscience Corporation | Open-market sale | −4,573 | $135.40 | $619,193 |
| Oct 5, 2026 | Twist Bioscience Corporation | Open-market sale | −1,840 | $200.44 | $368,806 |
| Oct 5, 2026 | Twist Bioscience Corporation | Open-market sale | −481 | $201.26 | $96,804 |
| Oct 5, 2026 | Twist Bioscience Corporation | Open-market sale | −1,017 | $202.32 | $205,763 |
| Oct 5, 2026 | Twist Bioscience Corporation | Open-market sale | −432 | $203.61 | $87,958 |
| Oct 5, 2026 | Twist Bioscience Corporation | Open-market sale | −290 | $204.80 | $59,392 |
| Oct 5, 2026 | Twist Bioscience Corporation | Open-market sale | −297 | $205.78 | $61,116 |
| Oct 5, 2026 | Twist Bioscience Corporation | Open-market sale | −146 | $206.84 | $30,199 |
| Oct 5, 2026 | Twist Bioscience Corporation | Open-market sale | −45 | $207.46 | $9,336 |
| Oct 2, 2026 | Twist Bioscience Corporation | Open-market sale | −45,736 | $188.88 | $8,638,799 |
| Oct 1, 2026 | Twist Bioscience Corporation | Open-market sale | −655 | $200.00 | $131,000 |
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −2,485 | $175.23 | $435,447 |
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −945 | $176.39 | $166,689 |
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −164 | $177.17 | $29,056 |
| Sep 24, 2026 | Twist Bioscience Corporation | Open-market sale | −330 | $178.67 | $58,961 |
Questions about Emily M. Leproust
What boards is Emily M. Leproust on?
Emily M. Leproust sits on the boards of GeneDx Holdings Corp. and Twist Bioscience Corporation.
What company is Emily M. Leproust the CEO of?
Emily M. Leproust is Chief Executive Officer of Twist Bioscience Corporation.
How long has Emily M. Leproust served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.